C-Path's PRO Consortium receives COA qualification from FDA for asthma symptom diaries

(Critical Path Institute (C-Path)) Critical Path Institute's Patient-Reported Outcome Consortium announces US Food and Drug Administration qualification of two new clinical outcome assessment tools: the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD). The qualification of the ADSD and the ANSD represents a major milestone for the PRO Consortium and is the culmination of a multi-year collaboration between FDA's Center for Drug Evaluation and Research and the PRO Consortium.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2uW75Yw